Recently, Roolf et al, reported that decitabine induced a significant delay of leukemic progression in vivo in mouse xenografts of the MLL‐rearranged ALL cell lines SEM and RS4;11, but could not eradicate the leukemia [42]. Here, KMT2A is linked to leukemia.